Literature DB >> 19885807

The influence of peptides from the angiotensin family on tyrosine kinase activity and cell viability in a human hormone-dependent prostate cancer line.

Kamila Domińska1, Agnieszka Wanda Piastowska, Elzbieta Rebas, Agnieszka Lachowicz-Ochedalska.   

Abstract

INTRODUCTION: The results of many studies have reported that peptides from the angiotensin family are involved in the regulation of cell growth, proliferation, cell migration, apoptosis, inflammation, differentiation, and angiogenesis, which suggests that they might play an important role in carcinogenesis. The role of the renin-angiotensin system in supporting prostate cancer induction and progression has so far received little study.
MATERIAL AND METHODS: The present study was to examine the influence of Ang II, Ang III, and Ang IV on a human hormone-dependent prostate cancer line (LNCaP). Using an isotopic method, we tested the effects of angiotensins on tyrosine kinase activity, and measured cell viability using an MTT Assay.
RESULTS: The results showed that only Ang IV significantly reduced tyrosine kinase activity and cell viability in LNCaP cells. The process seemed to be mediated partly by AT(2) and probably by another type of receptor with high affinity for Ang IV and low affinity for PD123319 and Losartan.
CONCLUSIONS: These findings suggest that components of the renin-angiotensin system, specifically angiotensin peptides and receptors (AT(1), AT(2)) can modify prostate cancer cell viability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885807

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  4 in total

1.  A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.

Authors:  Kamila Domińska; Tomasz Ochędalski; Karolina Kowalska; Zuzanna E Matysiak-Burzyńska; Elżbieta Płuciennik; Agnieszka W Piastowska-Ciesielska
Journal:  J Physiol Biochem       Date:  2016-04-27       Impact factor: 4.158

2.  Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.

Authors:  Aino Siltari; Teemu J Murtola; Kirsi Talala; Kimmo Taari; Teuvo L J Tammela; Anssi Auvinen
Journal:  PLoS One       Date:  2020-06-29       Impact factor: 3.240

3.  Effect of an angiotensin II type 1 receptor blocker on caveolin-1 expression in prostate cancer cells.

Authors:  Agnieszka Wanda Piastowska-Ciesielska; Marcin Kozłowski; Waldemar Wagner; Kamila Domińska; Tomasz Ochędalski
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

4.  Immunohistochemical detection of angiotensin AT 1 and AT 2 receptors in prostate cancer.

Authors:  Marek Pawlikowski; Radosław Minias; Marek Sosnowski; Krzysztof W Zieliński
Journal:  Cent European J Urol       Date:  2011-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.